The Effect of Neuroepo on Cognition in Parkinson’s Disease Patients Is Mediated by Electroencephalogram Source Activity

We report on the quantitative electroencephalogram (qEEG) and cognitive effects of Neuroepo in Parkinson’s disease (PD) from a double-blind safety trial (https://clinicaltrials.gov/, number NCT04110678). Neuroepo is a new erythropoietin (EPO) formulation with a low sialic acid content with satisfact...

Descripción completa

Detalles Bibliográficos
Autores principales: Bringas Vega, Maria L., Pedroso Ibáñez, Ivonne, Razzaq, Fuleah A., Zhang, Min, Morales Chacón, Lilia, Ren, Peng, Galan Garcia, Lidice, Gan, Peng, Virues Alba, Trinidad, Lopez Naranjo, Carlos, Jahanshahi, Marjan, Bosch-Bayard, Jorge, Valdes-Sosa, Pedro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280298/
https://www.ncbi.nlm.nih.gov/pubmed/35844232
http://dx.doi.org/10.3389/fnins.2022.841428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280298/
https://www.ncbi.nlm.nih.gov/pubmed/35844232
http://dx.doi.org/10.3389/fnins.2022.841428

Ejemplares similares